HM Lokhorst - Concepedia

Author

HM Lokhorst

Utrecht University

Also Known As

H Lokhorst, H M LOKHORST, H M Lokhorst, H. M. LOKHORST, H. M. Lokhorst, H.M Lokhorst, H.M. Lokhorst, HM Lokhorst

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Utrecht University University Medical Center Utrecht University of Southern Denmark Genmab (Netherlands)Amsterdam UMC Location University of Amsterdam

About

HM Lokhorst is an author at Utrecht University specializing in medicine, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	455
2	Health Sciences	2	2	92
3	Clinical Immunology	2	2	82
4	Blood Transplantation	1	1	242
5	Cellular Therapies	1	1	70

HM Lokhorst

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Donor Leukocyte Infusions Are Effective in Relapsed Multiple Myeloma After Allogeneic Bone Marrow Transplantation HM Lokhorst, A Schattenberg, J.J. Cornelissen, Blood	1997	297
Graft-versus-myeloma effect in two cases LF Verdonck, HM Lokhorst, AW Dekker, The Lancet TransplantationMarrow TransplantationHematologyGraft SurvivalSurgery	1996	242
Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab Michael S. van der Veer, Michel de Weers, Berris van Kessel, Haematologica	2010	216
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma Esther Drent, Richard W.J. Groen, Willy A. Noort, Haematologica	2016	196
Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures HM Lokhorst, Tanja Lamme, Martin De Smet, Blood	1994	158
Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma EJ Ahsmann, HM Lokhorst, AW Dekker, Blood	1992	89
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft [see comments] LF Verdonck, AW Dekker, GC de Gast, Blood	1994	88
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells LF Verdonck, EJ Petersen, HM Lokhorst, Bone Marrow Transplantation Cell TherapyTransplantationMarrow TransplantationMedicineStem Cell Transplantation	1998	70
Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma XS Xu, Xiaoyu Yan, Thomas A. Puchalski, Clinical Pharmacology & Therapeutics	2016	67
Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop. H C van Zaanen, Richard P. Koopmans, L Aarden, Journal of Clinical Investigation Clinical ImmunologyImmunologyPathologyMetronomic ChemotherapyImmunotherapy	1996	55

Page 1